Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jack W Schuler. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jack W Schuler har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BDSX / Biodesix, Inc. | Director, 10% Owner | 24 406 546 |
US:AXDX / Accelerate Diagnostics, Inc. | Director, 10% Owner | 8 310 388 |
US:AWH / Aspira Women's Health Inc. | 10% Owner | 6 536 |
US:YTEN / Yield10 Bioscience, Inc. | 10% Owner | 63 789 |
US:SLNO / Soleno Therapeutics, Inc. | 10% Owner | 46 595 |
US:QDEL / QuidelOrtho Corporation | Director, 10% Owner | 0 |
US:BIOL / BIOLASE, Inc. | 10% Owner | 739 820 |
US:SRCL / Stericycle, Inc. | Director | 2 078 |
10% Owner | 4 677 342 | |
US:HNSN / Hansen Medical, Inc. | Director, 10% Owner | 60 000 |
10% Owner | 6 165 261 | |
Director | 21 910 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jack W Schuler. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp AWHL / Aspira Women's Health Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp BDSX / Biodesix, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp QDEL / QuidelOrtho Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp SLNO / Soleno Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp YTENQ / Yield10 Bioscience, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AWHL / Aspira Women's Health Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jack W Schuler som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 3 488 372 | 24 406 546 | 16,68 | 0,43 | 1 500 000 | 10 494 815 | |
2025-05-20 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 723 239 | 20 918 174 | 3,58 | 0,34 | 246 624 | 7 133 097 | |
2025-05-20 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 4 000 000 | 20 194 935 | 24,70 | 0,27 | 1 070 000 | 5 402 145 | |
2024-12-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
S - Sale | −200 000 | 8 310 388 | −2,35 | 1,57 | −314 000 | 13 047 309 | |
2024-11-22 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 100 000 | 31 194 935 | 0,32 | 1,23 | 122 840 | 38 319 858 | |
2024-11-21 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 200 000 | 31 094 935 | 0,65 | 1,17 | 234 000 | 36 381 074 | |
2024-11-06 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 100 253 | 30 894 935 | 0,33 | 1,36 | 136 585 | 42 091 259 | |
2024-07-11 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock |
P - Purchase | 6 536 | 6 536 | |||||
2024-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 4 737 | 20 225 | 30,58 | ||||
2024-06-18 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock |
P - Purchase | 28 500 | 1 912 156 | 1,51 | ||||
2024-05-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 7 894 | 15 488 | 103,95 | ||||
2024-05-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
M - Exercise | 86 960 | 30 794 682 | 0,28 | ||||
2024-05-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 1 560 694 | 8 510 388 | 22,46 | ||||
2024-05-17 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −36 000 | 63 789 | −36,08 | 0,20 | −7 200 | 12 758 | |
2024-01-25 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 1 156 069 | 6 949 694 | 19,95 | ||||
2023-12-20 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −36 000 | 1 566 956 | −2,25 | 0,21 | −7 430 | 323 420 | |
2023-12-11 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −35 000 | 1 602 956 | −2,14 | 0,24 | −8 320 | 381 023 | |
2023-10-10 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 765 000 | 1 637 956 | 87,63 | 0,65 | 497 250 | 1 064 671 | |
2023-10-06 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −37 931 | 872 956 | −4,16 | 0,30 | −11 448 | 263 458 | |
2023-10-06 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −10 670 | 910 887 | −1,16 | 0,30 | −3 216 | 274 541 | |
2023-10-06 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −41 399 | 921 557 | −4,30 | 0,31 | −12 867 | 286 420 | |
2023-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 87 500 | 30 707 722 | 0,29 | 1,71 | 149 240 | 52 375 091 | |
2023-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 8 307 | 30 620 222 | 0,03 | 1,67 | 13 859 | 51 083 716 | |
2023-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 32 556 | 30 611 915 | 0,11 | 1,64 | 53 411 | 50 221 908 | |
2023-08-11 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
A - Award | 9 989 506 | 30 579 359 | 48,52 | 1,62 | 16 183 000 | 49 538 562 | |
2023-07-25 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
P - Purchase | 181 800 | 1 883 656 | 10,68 | 2,75 | 499 950 | 5 180 054 | |
2023-06-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 34 321 163 | 57 936 258 | 145,34 | 1,06 | 36 380 433 | 61 412 433 | |
2023-06-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 4 878 048 | 23 615 095 | 26,03 | 0,82 | 3 999 999 | 19 364 378 | |
2023-06-01 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 14 792 | 20 589 853 | 0,07 | 1,35 | 20 006 | 27 847 776 | |
2023-06-01 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 11 849 | 20 575 061 | 0,06 | 1,36 | 16 150 | 28 043 808 | |
2023-06-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 75 949 | 75 949 | |||||
2023-05-30 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 52 508 | 20 563 212 | 0,26 | 1,36 | 71 280 | 27 914 560 | |
2023-05-26 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 35 308 | 20 510 704 | 0,17 | 1,25 | 43 980 | 25 548 133 | |
2023-05-25 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 56 782 | 20 475 396 | 0,28 | 1,15 | 65 066 | 23 462 756 | |
2023-05-24 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 29 425 | 20 418 614 | 0,14 | 1,11 | 32 529 | 22 572 778 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 46 595 | −17,67 | 0,93 | −9 300 | 43 333 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 56 595 | −15,02 | 0,96 | −9 600 | 54 331 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 66 595 | −13,06 | 0,99 | −9 900 | 65 929 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 76 595 | −11,55 | 0,97 | −9 700 | 74 297 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 86 595 | −10,35 | 1,00 | −10 000 | 86 595 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 96 595 | −9,38 | 1,03 | −10 300 | 99 493 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 106 595 | −8,58 | 0,99 | −9 900 | 105 529 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 116 595 | −7,90 | 1,01 | −10 100 | 117 761 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 126 595 | −7,32 | 1,05 | −10 500 | 132 925 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 136 595 | −6,82 | 1,07 | −10 700 | 146 157 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 400 | 146 595 | −6,62 | 1,11 | −11 544 | 162 720 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 156 995 | −5,99 | 1,07 | −10 700 | 167 985 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −14 531 | 166 995 | −8,00 | 1,13 | −16 420 | 188 704 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −28 474 | 181 526 | −13,56 | 1,15 | −32 745 | 208 755 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −11 442 | 210 000 | −5,17 | 1,15 | −13 158 | 241 500 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −116 882 | 221 442 | −34,55 | 1,26 | −147 271 | 279 017 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 338 324 | −2,87 | 1,09 | −10 900 | 368 773 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 348 324 | −2,79 | 1,07 | −10 700 | 372 707 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 358 324 | −2,72 | 0,94 | −9 400 | 336 825 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 368 324 | −2,64 | 0,99 | −9 900 | 364 641 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 378 324 | −2,58 | 0,99 | −9 900 | 374 541 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 388 324 | −2,51 | 0,99 | −9 900 | 384 441 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 398 324 | −2,45 | 1,01 | −10 100 | 402 307 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 408 324 | −2,39 | 0,97 | −9 700 | 396 074 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 418 324 | −2,33 | 0,99 | −9 900 | 414 141 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 428 324 | −2,28 | 1,00 | −10 000 | 428 324 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 438 324 | −2,23 | 1,08 | −10 800 | 473 390 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −9 100 | 448 324 | −1,99 | 1,16 | −10 556 | 520 056 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −8 842 | 457 424 | −1,90 | 1,26 | −11 141 | 576 354 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −400 | 466 266 | −0,09 | 1,52 | −608 | 708 724 | |
2023-05-15 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 000 | 36 595 | −21,46 | 0,91 | −9 100 | 33 301 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 708 858 | −0,42 | 2,19 | −6 570 | 1 552 399 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 711 858 | −0,42 | 2,33 | −6 990 | 1 658 629 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 714 858 | −0,42 | 2,36 | −7 080 | 1 687 065 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 717 858 | −0,42 | 2,47 | −7 410 | 1 773 109 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 720 858 | −0,41 | 2,44 | −7 320 | 1 758 894 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 723 858 | −0,41 | 2,72 | −8 160 | 1 968 894 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 726 858 | −0,41 | 2,70 | −8 100 | 1 962 517 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 400 | 729 858 | −0,46 | 2,41 | −8 194 | 1 758 958 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 733 258 | −0,41 | 2,49 | −7 470 | 1 825 812 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 736 258 | −0,41 | 2,45 | −7 350 | 1 803 832 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −1 400 | 739 258 | −0,19 | 2,53 | −3 542 | 1 870 323 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 740 658 | −0,40 | 2,81 | −8 430 | 2 081 249 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 743 658 | −0,40 | 2,97 | −8 910 | 2 208 664 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −9 851 | 746 658 | −1,30 | 3,01 | −29 652 | 2 247 441 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 158 | 756 509 | −0,55 | 3,01 | −12 516 | 2 277 092 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 000 | 760 667 | −0,52 | 3,03 | −12 120 | 2 304 821 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −7 420 | 764 667 | −0,96 | 3,03 | −22 483 | 2 316 941 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 141 | 772 087 | −0,41 | 3,07 | −9 643 | 2 370 307 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 625 | 775 228 | −0,59 | 3,06 | −14 152 | 2 372 198 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −20 338 | 779 853 | −2,54 | 3,09 | −62 844 | 2 409 746 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 200 | 800 191 | −0,52 | 3,14 | −13 188 | 2 512 600 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 259 | 804 391 | −0,53 | 3,22 | −13 714 | 2 590 139 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −13 822 | 808 650 | −1,68 | 3,35 | −46 304 | 2 708 978 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −25 343 | 822 472 | −2,99 | 3,34 | −84 646 | 2 747 056 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 847 815 | −0,35 | 3,20 | −9 600 | 2 713 008 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 000 | 850 815 | −0,35 | 2,88 | −8 640 | 2 450 347 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −1 200 | 853 815 | −0,14 | 2,85 | −3 420 | 2 433 373 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −900 | 855 015 | −0,11 | 2,96 | −2 664 | 2 530 844 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −200 | 855 915 | −0,02 | 2,90 | −580 | 2 482 154 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 901 | 856 115 | −0,57 | 2,96 | −14 507 | 2 534 100 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −608 | 627 386 | −0,10 | 1,78 | −1 082 | 1 116 747 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −5 100 | 627 994 | −0,81 | 1,76 | −8 976 | 1 105 269 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −7 000 | 633 094 | −1,09 | 1,82 | −12 740 | 1 152 231 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −6 324 | 640 094 | −0,98 | 1,88 | −11 889 | 1 203 377 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −18 192 | 646 418 | −2,74 | 1,89 | −34 383 | 1 221 730 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −7 000 | 664 610 | −1,04 | 1,75 | −12 250 | 1 163 068 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −4 292 | 671 610 | −0,64 | 1,80 | −7 726 | 1 208 898 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −10 152 | 675 902 | −1,48 | 1,88 | −19 086 | 1 270 696 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −5 300 | 686 054 | −0,77 | 1,91 | −10 123 | 1 310 363 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −3 504 | 691 354 | −0,50 | 1,91 | −6 693 | 1 320 486 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −7 000 | 694 858 | −1,00 | 1,96 | −13 720 | 1 361 922 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −7 000 | 701 858 | −0,99 | 2,06 | −14 420 | 1 445 827 | |
2023-05-09 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 335 570 | 962 956 | 53,49 | 2,98 | 999 999 | 2 869 609 | |
2023-02-01 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 10 000 | 20 389 189 | 0,05 | 2,41 | 24 100 | 49 137 945 | |
2023-01-31 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 50 000 | 20 379 189 | 0,25 | 2,51 | 125 430 | 51 123 234 | |
2023-01-31 |
|
4/A | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 10 000 | 20 319 189 | 0,05 | 1,65 | 16 476 | 33 477 896 | |
2022-12-20 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 10 000 | 20 339 189 | 0,05 | 1,70 | 17 000 | 34 576 621 | |
2022-12-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20 000 | 20 329 189 | 0,10 | 1,65 | 32 952 | 33 494 372 | |
2022-12-16 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 189 675 | 20 309 189 | 0,94 | 1,65 | 312 945 | 33 508 131 | |
2022-12-15 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 67 402 | 20 119 514 | 0,34 | 1,58 | 106 529 | 31 798 892 | |
2022-12-14 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 100 000 | 20 052 112 | 0,50 | 1,48 | 148 380 | 29 753 324 | |
2022-11-21 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 8 695 652 | 19 952 112 | 77,25 | 1,15 | 10 000 000 | 22 944 929 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −22 681 | 466 666 | −4,63 | 2,41 | −54 675 | 1 124 945 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −8 394 | 489 347 | −1,69 | 2,42 | −20 345 | 1 186 030 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 888 | 497 741 | −2,14 | 2,50 | −27 231 | 1 244 850 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −173 | 508 629 | −0,03 | 2,62 | −454 | 1 334 693 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −4 571 | 508 802 | −0,89 | 2,68 | −12 231 | 1 361 402 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −7 876 | 513 373 | −1,51 | 2,73 | −21 493 | 1 400 944 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −10 833 | 521 249 | −2,04 | 2,80 | −30 372 | 1 461 426 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −5 212 | 532 082 | −0,97 | 2,90 | −15 105 | 1 542 027 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −7 718 | 537 294 | −1,42 | 2,88 | −22 245 | 1 548 589 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −53 333 | 545 012 | −8,91 | 2,93 | −156 378 | 1 598 030 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −16 667 | 598 345 | −2,71 | 2,65 | −44 238 | 1 588 127 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −2 675 | 615 012 | −0,43 | 2,72 | −7 264 | 1 670 004 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −8 006 | 617 687 | −1,28 | 2,65 | −21 184 | 1 634 400 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −6 824 | 625 693 | −1,08 | 2,64 | −18 014 | 1 651 704 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −6 696 | 632 517 | −1,05 | 2,52 | −16 894 | 1 595 840 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −5 103 | 639 213 | −0,79 | 2,46 | −12 551 | 1 572 208 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −2 520 | 644 316 | −0,39 | 2,54 | −6 389 | 1 633 534 | |
2022-10-14 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −353 | 646 836 | −0,05 | 2,55 | −901 | 1 650 984 | |
2022-08-29 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
P - Purchase | 133 333 | 25 527 850 | 0,53 | ||||
2022-05-26 |
|
4 | BDSX |
BIODESIX INC
Restricted Stock Units |
A - Award | 83 333 | 83 333 | |||||
2022-04-11 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 2 793 296 | 11 256 460 | 33,01 | 1,79 | 5 000 000 | 20 149 063 | |
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 4 000 000 | 4 000 000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 4 000 000 | 7 911 804 | 102,25 | ||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −800 | 3 911 804 | −0,02 | 0,35 | −284 | 1 387 908 | |
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −100 000 | 3 912 604 | −2,49 | 0,88 | −87 600 | 3 427 441 | |
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −2 599 | 4 012 604 | −0,06 | 0,87 | −2 270 | 3 505 010 | |
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −49 841 | 4 015 203 | −1,23 | 0,78 | −39 120 | 3 151 533 | |
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −19 748 | 4 065 044 | −0,48 | 0,86 | −17 074 | 3 514 637 | |
2022-01-31 |
|
4/A | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 2 298 850 | 8 463 164 | 37,29 | 4,35 | 9 999 998 | 36 814 763 | |
2022-01-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 41 912 | 18 737 047 | 0,22 | 3,94 | 165 133 | 73 823 965 | |
2022-01-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 31 219 | 18 695 135 | 0,17 | 3,89 | 121 442 | 72 724 075 | |
2022-01-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 000 | 18 663 916 | 0,54 | 4,03 | 403 000 | 75 215 581 | |
2022-01-12 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 45 226 | 18 563 916 | 0,24 | 4,34 | 196 281 | 80 567 395 | |
2022-01-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 18 518 690 | 0,05 | 4,93 | 49 300 | 91 297 142 | |
2022-01-04 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 997 | 18 508 690 | 0,01 | 4,95 | 4 935 | 91 618 016 | |
2022-01-04 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 2 298 850 | 8 463 164 | 37,29 | 4,35 | 9 999 998 | 36 814 763 | |
2021-12-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 27 062 | 18 507 693 | 0,15 | 4,83 | 130 709 | 89 392 157 | |
2021-12-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 30 000 | 18 480 631 | 0,16 | 4,87 | 146 100 | 90 000 673 | |
2021-12-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 54 541 | 18 450 631 | 0,30 | 4,73 | 257 979 | 87 271 485 | |
2021-12-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 74 127 | 18 396 090 | 0,40 | 4,98 | 369 152 | 91 612 528 | |
2021-12-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 18 321 963 | 0,11 | 4,60 | 92 000 | 84 281 030 | |
2021-12-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 17 050 | 18 301 963 | 0,09 | 4,38 | 74 679 | 80 162 598 | |
2021-11-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1 000 000 | 18 284 913 | 5,79 | 5,00 | 5 000 000 | 91 424 565 | |
2021-11-24 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20 000 | 6 164 314 | 0,33 | 6,34 | 126 756 | 39 068 189 | |
2021-11-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 48 987 | 17 284 913 | 0,28 | 5,06 | 247 874 | 87 461 660 | |
2021-11-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 60 000 | 6 144 314 | 0,99 | 6,50 | 390 186 | 39 957 088 | |
2021-11-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 56 850 | 17 235 926 | 0,33 | 5,19 | 295 052 | 89 454 456 | |
2021-11-22 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 28 361 | 6 084 314 | 0,47 | 6,33 | 179 502 | 38 508 840 | |
2021-11-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 116 444 | 17 179 076 | 0,68 | 5,20 | 605 509 | 89 331 195 | |
2021-11-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 20 000 | 6 055 953 | 0,33 | 6,51 | 130 104 | 39 395 185 | |
2021-10-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 54 975 | 54 975 | 9,08 | 499 173 | 499 173 | ||
2021-10-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
G - Gift | −689 355 | 0 | −100,00 | ||||
2021-09-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 59 978 | 17 062 632 | 0,35 | 5,31 | 318 483 | 90 602 576 | |
2021-09-29 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 150 000 | 17 002 654 | 0,89 | 5,33 | 799 500 | 90 624 146 | |
2021-09-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 192 200 | 16 852 654 | 1,15 | 5,45 | 1 047 490 | 91 846 964 | |
2021-09-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 27 353 | 16 660 454 | 0,16 | 5,50 | 150 442 | 91 632 497 | |
2021-08-23 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 50 000 | 6 035 953 | 0,84 | 7,69 | 384 440 | 46 409 235 | |
2021-08-19 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 29 440 | 5 985 953 | 0,49 | 7,18 | 211 447 | 42 992 910 | |
2021-08-17 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 232 000 | 5 956 513 | 4,05 | 7,50 | 1 739 490 | 44 660 743 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −41 195 | 9 707 848 | −0,42 | 1,03 | −42 456 | 10 004 908 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −248 115 | 9 749 043 | −2,48 | 1,14 | −283 149 | 11 125 608 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −5 625 | 9 997 158 | −0,06 | 1,25 | −7 031 | 12 496 448 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −80 498 | 10 002 783 | −0,80 | 1,26 | −101 065 | 12 558 494 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −250 000 | 10 083 281 | −2,42 | 1,20 | −300 425 | 12 117 079 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −248 636 | 10 333 281 | −2,35 | 1,21 | −300 800 | 12 501 203 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −187 985 | 4 084 792 | −4,40 | 2,67 | −501 920 | 10 906 395 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −172 717 | 4 272 777 | −3,89 | 2,62 | −452 570 | 11 195 958 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −200 | 10 581 917 | 0,00 | 2,71 | −542 | 28 676 995 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −700 | 4 445 494 | −0,02 | 2,97 | −2 079 | 13 205 784 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −258 300 | 10 582 117 | −2,38 | 2,95 | −762 527 | 31 239 468 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −14 700 | 4 446 194 | −0,33 | 2,13 | −31 312 | 9 470 838 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −100 | 10 840 417 | 0,00 | 2,05 | −205 | 22 222 855 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −12 763 | 10 840 517 | −0,12 | 2,05 | −26 209 | 22 261 002 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −12 818 | 10 853 280 | −0,12 | 2,06 | −26 363 | 22 321 941 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −72 591 | 10 866 098 | −0,66 | 2,09 | −151 592 | 22 691 672 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −15 566 | 10 938 689 | −0,14 | 2,10 | −32 642 | 22 938 431 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −20 277 | 10 954 255 | −0,18 | 2,10 | −42 484 | 22 951 355 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −29 723 | 10 974 532 | −0,27 | 2,05 | −61 078 | 22 551 566 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −35 231 | 4 460 894 | −0,78 | 2,11 | −74 436 | 9 424 977 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −102 000 | 11 004 255 | −0,92 | 1,99 | −203 153 | 21 917 175 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −98 862 | 11 106 255 | −0,88 | 1,90 | −188 194 | 21 141 867 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −520 | 11 205 117 | 0,00 | 1,95 | −1 014 | 21 845 496 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −33 697 | 11 205 637 | −0,30 | 1,95 | −65 783 | 21 875 645 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −63 746 | 11 239 334 | −0,56 | 1,85 | −118 185 | 20 837 725 | |
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
S - Sale | −65 782 | 11 303 080 | −0,58 | 1,91 | −125 367 | 21 541 410 | |
2021-07-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 29 577 | 16 633 101 | 0,18 | 9,20 | 272 108 | 153 024 529 | |
2021-07-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 1 267 023 | 0,40 | 16,04 | 80 200 | 20 323 049 | |
2021-07-01 |
|
4 | BDSX |
BIODESIX INC
Stock Options (Right to buy) |
A - Award | 34 385 | 34 385 | |||||
2021-05-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 35 168 | 35 168 | |||||
2021-02-04 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 54 132 | 1 262 023 | 4,48 | 9,87 | 534 283 | 12 456 167 | |
2021-02-04 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 101 400 | 895 035 | 12,78 | 12,25 | 1 242 150 | 10 964 179 | |
2021-02-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 100 000 | 1 207 891 | 9,03 | 11,40 | 1 140 000 | 13 769 957 | |
2021-02-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 30 868 | 1 107 891 | 2,87 | 10,18 | 314 236 | 11 278 330 | |
2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Stock Options (Right to Buy) |
M - Exercise | −23 440 | 11 718 | −66,67 | ||||
2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Stock Options (Right to Buy) |
M - Exercise | −35 157 | 1 | −100,00 | ||||
2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
M - Exercise | 23 440 | 5 725 419 | 0,41 | 6,83 | 160 095 | 39 104 612 | |
2020-12-09 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
M - Exercise | 35 157 | 5 701 979 | 0,62 | 6,83 | 240 122 | 38 944 517 | |
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series B Preferred Stock |
C - Conversion | −1 454 545 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
3% Convertible Debt due June 2021 |
C - Conversion | 0 | ||||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series H Preferred Stock |
C - Conversion | −5 366 411 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series G Preferred Stock |
C - Conversion | −9 419 362 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series F Preferred Stock |
C - Conversion | −6 273 780 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series E Preferred Stock |
C - Conversion | −1 759 853 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series D Preferred Stock |
C - Conversion | −3 101 784 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series C Preferred Stock |
C - Conversion | −333 333 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Series B-1 Preferred Stock |
C - Conversion | −1 250 000 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
P - Purchase | 277 777 | 277 777 | 18,00 | 4 999 986 | 4 999 986 | ||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
C - Conversion | 753 735 | 5 666 822 | 15,34 | 14,40 | 10 853 784 | 81 602 237 | |
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
C - Conversion | 245 041 | 4 913 087 | 5,25 | ||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
Common Stock |
C - Conversion | 4 668 046 | 4 668 046 | |||||
2020-11-03 |
|
4 | BDSX |
BIODESIX INC
3% Convertible Debt due June 2021 |
A - Award | |||||||
2020-08-31 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 365 241 | 793 635 | 85,26 | 4,25 | 1 552 274 | 3 372 949 | |
2020-07-06 |
|
4 | AWH |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
P - Purchase | 2 285 715 | 25 394 517 | 9,89 | 3,50 | 8 000 002 | 88 880 810 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 33 900 | 835 717 | 4,23 | 1,93 | 65 376 | 1 611 680 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10 572 | 801 817 | 1,34 | 1,99 | 20 991 | 1 592 008 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 800 | 791 245 | 0,10 | 2,00 | 1 600 | 1 582 490 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 7 300 | 790 445 | 0,93 | 2,00 | 14 600 | 1 580 890 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 200 | 783 145 | 0,03 | 1,99 | 398 | 1 558 459 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 800 | 782 945 | 0,10 | 1,98 | 1 581 | 1 547 334 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 200 | 782 145 | 0,03 | 1,96 | 392 | 1 533 004 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 8 448 | 781 945 | 1,09 | 1,97 | 16 629 | 1 539 181 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 1 200 | 773 497 | 0,16 | 1,99 | 2 388 | 1 539 259 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 5 000 | 772 297 | 0,65 | 2,03 | 10 130 | 1 564 596 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10 818 | 767 297 | 1,43 | 1,99 | 21 517 | 1 526 154 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 4 548 | 756 479 | 0,60 | 1,96 | 8 913 | 1 482 472 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 20 769 | 751 931 | 2,84 | 1,94 | 40 327 | 1 460 024 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10 562 | 731 162 | 1,47 | 1,99 | 20 981 | 1 452 453 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 21 953 | 720 600 | 3,14 | 1,99 | 43 675 | 1 433 634 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 6 000 | 698 647 | 0,87 | 2,08 | 12 496 | 1 455 072 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 2 100 | 692 647 | 0,30 | 2,03 | 4 262 | 1 405 727 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 47 293 | 690 547 | 7,35 | 2,05 | 97 026 | 1 416 726 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 30 000 | 643 254 | 4,89 | 2,14 | 64 197 | 1 376 499 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 10 000 | 613 254 | 1,66 | 2,09 | 20 871 | 1 279 922 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 5 000 | 603 254 | 0,84 | 1,95 | 9 748 | 1 176 164 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 146 230 | 598 254 | 32,35 | 1,96 | 286 260 | 1 171 142 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 11 243 | 452 024 | 2,55 | 2,09 | 23 492 | 944 504 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 8 970 | 440 781 | 2,08 | 2,11 | 18 936 | 930 489 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 100 000 | 431 811 | 30,14 | 2,05 | 204 580 | 883 399 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 42 745 | 331 811 | 14,79 | 2,23 | 95 415 | 740 669 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 30 014 | 289 066 | 11,59 | 2,31 | 69 347 | 667 887 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 147 645 | 259 052 | 132,53 | 2,37 | 350 155 | 614 368 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 111 407 | 111 407 | 2,32 | 258 275 | 258 275 | ||
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 1 666 667 | 6 217 345 | 36,62 | 1,20 | 2 000 000 | 7 460 814 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 897 083 | 1 732 800 | 107,34 | 1,20 | 1 076 500 | 2 079 360 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 2 424 242 | 4 157 042 | 139,90 | 1,65 | 3 999 999 | 6 859 119 | |
2020-06-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 5 151 517 | 11 368 862 | 82,86 | 1,65 | 8 500 003 | 18 758 622 | |
2020-06-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 95 492 | 16 603 524 | 0,58 | 9,86 | 941 551 | 163 710 747 | |
2020-06-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 134 080 | 16 508 032 | 0,82 | 9,34 | 1 252 307 | 154 185 019 | |
2020-06-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 129 000 | 16 373 952 | 0,79 | 9,18 | 1 184 220 | 150 312 879 | |
2020-06-12 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 000 | 16 244 952 | 0,62 | 9,84 | 984 000 | 159 850 328 | |
2020-06-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 339 083 | 2 071 883 | 19,57 | 1,97 | 666 807 | 4 074 358 | |
2020-06-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 180 955 | 16 144 952 | 1,13 | 9,63 | 1 742 597 | 155 475 888 | |
2020-06-11 |
|
4 | VRML |
Aspira Women's Health Inc.
Warrants (Right to buy) |
X - Other | −730 560 | 0 | −100,00 | ||||
2020-06-11 |
|
4 | VRML |
Aspira Women's Health Inc.
Common Stock, par value $0.001 |
X - Other | 730 560 | 23 108 802 | 3,26 | 1,80 | 1 315 008 | 41 595 844 | |
2020-06-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1 100 000 | 15 963 997 | 7,40 | 8,58 | 9 438 000 | 136 971 094 | |
2020-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units |
M - Exercise | −2 100 | 0 | −100,00 | ||||
2020-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 2 100 | 3 103 249 | 0,07 | ||||
2020-05-15 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
S - Sale | −1 307 931 | 739 820 | −63,87 | 0,60 | −784 759 | 443 892 | |
2020-05-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 89 055 | 14 863 997 | 0,60 | 9,46 | 842 460 | 140 613 412 | |
2020-05-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 14 774 942 | 0,14 | 9,92 | 198 400 | 146 567 425 | |
2020-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 1 040 | 1 040 | |||||
2020-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 82 | 82 | |||||
2020-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 273 | 273 | |||||
2020-05-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 14 754 942 | 0,14 | 9,99 | 199 800 | 147 401 871 | |
2020-05-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 25 000 | 14 734 942 | 0,17 | 9,87 | 246 750 | 145 433 878 | |
2020-05-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 868 | 14 709 942 | 0,07 | 10,00 | 108 680 | 147 099 420 | |
2020-05-07 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 8 625 | 14 699 074 | 0,06 | 10,00 | 86 250 | 146 990 740 | |
2020-05-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1 204 | 14 690 449 | 0,01 | 9,98 | 12 016 | 146 610 681 | |
2020-05-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 4 000 | 14 689 245 | 0,03 | 10,03 | 40 120 | 147 333 127 | |
2020-04-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 5 001 | 14 685 245 | 0,03 | 10,00 | 50 010 | 146 852 450 | |
2020-04-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 81 621 | 14 680 244 | 0,56 | 9,90 | 808 048 | 145 334 416 | |
2020-04-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 157 688 | 14 598 623 | 1,09 | 9,47 | 1 493 305 | 138 248 960 | |
2020-04-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 79 650 | 14 440 935 | 0,55 | 9,01 | 717 646 | 130 112 824 | |
2020-04-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 59 357 | 14 361 285 | 0,42 | 9,40 | 557 956 | 134 996 079 | |
2020-04-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
G - Gift | −1 100 000 | 1 077 023 | −50,53 | ||||
2020-04-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 13 779 | 13 779 | |||||
2020-04-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 120 000 | 14 301 928 | 0,85 | 8,30 | 996 000 | 118 706 002 | |
2020-04-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 80 000 | 14 181 928 | 0,57 | 8,59 | 687 200 | 121 822 762 | |
2020-03-31 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 101 963 | 14 101 928 | 0,73 | 8,09 | 824 881 | 114 084 598 | |
2020-03-30 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 148 037 | 13 999 965 | 1,07 | 8,04 | 1 190 217 | 112 559 719 | |
2020-03-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 12 290 | 12 290 | |||||
2020-03-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 150 000 | 13 851 928 | 1,09 | 7,70 | 1 155 000 | 106 659 846 | |
2020-03-27 |
|
4/A | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 150 000 | 13 701 928 | 1,11 | 6,92 | 1 038 000 | 94 817 342 | |
2020-03-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 150 000 | 13 701 928 | 1,11 | 6,92 | 1 038 000 | 94 817 342 | |
2020-03-25 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 172 900 | 13 551 928 | 1,29 | 5,89 | 1 018 381 | 79 820 856 | |
2020-02-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 9 000 | 13 379 028 | 0,07 | 15,39 | 138 510 | 205 903 241 | |
2020-02-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 10 000 | 13 370 028 | 0,07 | 15,84 | 158 400 | 211 781 244 | |
2020-02-25 |
|
4/A | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 13 360 028 | 0,07 | 16,32 | 163 200 | 218 035 657 | |
2020-02-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 13 350 028 | 0,07 | 16,06 | 160 600 | 214 401 450 | |
2020-02-12 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −42 697 | 428 396 | −9,06 | 7,69 | −328 225 | 3 293 209 | |
2020-02-12 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
S - Sale | −28 256 | 471 093 | −5,66 | 7,90 | −223 180 | 3 720 928 | |
2020-02-12 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 9 852 | 489 496 | 2,05 | 7,90 | 77 880 | 3 869 466 | |
2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series B Convertible Preferred Stock |
C - Conversion | −3 155 | 0 | −100,00 | 1 000,00 | −3 155 000 | ||
2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
C - Conversion | 374 375 | 489 946 | 323,94 | ||||
2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series B Convertible Preferred Stock |
P - Purchase | 3 155 | 3 155 | 1 000,00 | 3 155 000 | 3 155 000 | ||
2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series B Warrants |
P - Purchase | 3 155 | 3 155 | 1 000,00 | 3 155 000 | 3 155 000 | ||
2020-01-30 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Series A Warrants |
P - Purchase | 3 155 | 3 155 | 1 000,00 | 3 155 000 | 3 155 000 | ||
2019-12-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 177 023 | 0,23 | 15,72 | 78 600 | 34 222 802 | |
2019-12-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 172 023 | 0,23 | 15,94 | 79 700 | 34 622 047 | |
2019-11-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 167 023 | 0,23 | 15,75 | 78 750 | 34 130 612 | |
2019-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
2.50% Convertible Senior Notes due 2023 |
J - Other | 1 506 194,00 | ||||||
2019-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 162 023 | 0,23 | 15,32 | 76 600 | 33 122 192 | |
2019-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 2 157 023 | 0,47 | 15,18 | 151 800 | 32 743 609 | |
2019-08-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 2 147 023 | 0,47 | 18,00 | 180 000 | 38 646 414 | |
2019-08-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 137 023 | 0,23 | 18,29 | 91 450 | 39 086 151 | |
2019-08-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 132 023 | 0,24 | 18,37 | 91 850 | 39 165 263 | |
2019-08-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 2 127 023 | 0,47 | 17,89 | 178 900 | 38 052 441 | |
2019-08-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 117 023 | 0,24 | 18,20 | 91 000 | 38 529 819 | |
2019-08-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 5 000 | 2 112 023 | 0,24 | 18,08 | 90 400 | 38 185 376 | |
2019-08-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 2 107 023 | 0,48 | 17,45 | 174 500 | 36 767 551 | |
2019-07-02 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
P - Purchase | 5 000 000 | 22 378 242 | 28,77 | 0,80 | 4 000 000 | 17 902 594 | |
2019-06-05 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 552 427 | 3 822 908 | 16,89 | 1,21 | 668 492 | 4 626 101 | |
2019-06-05 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock Warrants |
P - Purchase | 1 906 744 | 2 366 838 | 414,42 | 0,05 | 95 337 | 118 342 | |
2019-06-05 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 1 906 744 | 3 270 481 | 139,82 | 2,26 | 4 309 241 | 7 391 287 | |
2019-06-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 700 | 2 097 023 | 0,51 | 18,77 | 200 839 | 39 361 122 | |
2019-05-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 32 600 | 2 086 323 | 1,59 | 18,87 | 615 162 | 39 368 915 | |
2019-05-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 2 053 723 | 0,49 | 19,06 | 190 600 | 39 143 960 | |
2019-05-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 19 300 | 2 043 723 | 0,95 | 19,02 | 367 086 | 38 871 611 | |
2019-05-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 50 000 | 2 024 423 | 2,53 | 19,03 | 951 500 | 38 524 770 | |
2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 1 661 | 3 101 149 | 0,05 | ||||
2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 2 100 | 2 100 | |||||
2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 262 | 262 | |||||
2019-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 875 | 875 | |||||
2019-02-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 1 974 423 | 0,51 | 18,48 | 184 800 | 36 487 337 | |
2019-01-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20 000 | 1 964 423 | 1,03 | 14,57 | 291 400 | 28 621 643 | |
2018-12-27 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20 000 | 1 944 423 | 1,04 | 10,53 | 210 600 | 20 474 774 | |
2018-12-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20 000 | 1 924 423 | 1,05 | 10,44 | 208 800 | 20 090 976 | |
2018-12-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock Warrant (Right to Buy) |
P - Purchase | 151 550 | 1 276 110 | 13,48 | ||||
2018-12-26 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") |
P - Purchase | 3 031 002 | 4 550 678 | 199,45 | 1,61 | 4 868 699 | 7 309 754 | |
2018-12-26 | 3 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
3 039 352 | ||||||||
2018-12-26 | 3 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
3 039 352 | ||||||||
2018-12-26 | 3 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
3 039 352 | ||||||||
2018-12-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20 000 | 1 904 423 | 1,06 | 10,88 | 217 600 | 20 720 122 | |
2018-12-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20 000 | 1 884 423 | 1,07 | 11,21 | 224 200 | 21 124 382 | |
2018-12-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 25 000 | 1 864 423 | 1,36 | 11,86 | 296 500 | 22 112 057 | |
2018-12-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 25 000 | 1 839 423 | 1,38 | 12,37 | 309 250 | 22 753 663 | |
2018-12-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 15 000 | 1 814 423 | 0,83 | 12,86 | 192 900 | 23 333 480 | |
2018-12-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 50 000 | 1 799 423 | 2,86 | 13,23 | 661 500 | 23 806 366 | |
2018-12-12 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 34 000 | 1 749 423 | 1,98 | 13,83 | 470 220 | 24 194 520 | |
2018-12-11 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 1 715 423 | 0,59 | 13,89 | 138 900 | 23 827 225 | |
2018-12-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 1 705 423 | 0,59 | 13,97 | 139 700 | 23 824 759 | |
2018-11-29 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 1 695 423 | 0,59 | 12,95 | 129 500 | 21 955 728 | |
2018-11-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 10 000 | 1 685 423 | 0,60 | 12,98 | 129 800 | 21 876 791 | |
2018-11-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 25 000 | 1 675 423 | 1,51 | 12,95 | 323 750 | 21 696 728 | |
2018-11-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 20 000 | 1 650 423 | 1,23 | 14,24 | 284 800 | 23 502 024 | |
2018-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 19 500 | 1 630 423 | 1,21 | 14,37 | 280 215 | 23 429 179 | |
2018-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 80 500 | 1 610 923 | 5,26 | 15,01 | 1 208 305 | 24 179 954 | |
2018-06-25 |
|
4 | VRML |
VERMILLION, INC.
Series B Convertible Preferred Stock (Right to Buy) |
C - Conversion | −39 619 | 0 | −100,00 | ||||
2018-06-25 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
C - Conversion | 3 961 900 | 17 378 242 | 29,53 | 1,00 | 3 961 900 | 17 378 242 | |
2018-05-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 13 340 028 | 0,08 | 20,00 | 200 000 | 266 800 560 | |
2018-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 1 661 | 1 661 | |||||
2018-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 200 | 200 | |||||
2018-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 667 | 667 | |||||
2018-05-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 65 000 | 13 330 028 | 0,49 | 19,97 | 1 298 050 | 266 200 659 | |
2018-05-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 22 200 | 13 265 028 | 0,17 | 19,88 | 441 336 | 263 708 757 | |
2018-05-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 77 800 | 13 242 828 | 0,59 | 19,17 | 1 491 426 | 253 865 013 | |
2018-05-02 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 170 | 2 078 | 8,91 | ||||
2018-04-19 |
|
4 | VRML |
VERMILLION, INC.
Series B Convertible Preferred Stock (Right to Buy) |
P - Purchase | 39 619 | 39 619 | 100,00 | 3 961 900 | 3 961 900 | ||
2018-04-19 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
P - Purchase | 2 838 090 | 13 416 342 | 26,83 | 1,00 | 2 838 090 | 13 416 342 | |
2018-04-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 9 476 | 9 476 | |||||
2018-03-07 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 1 530 423 | 0,01 | 25,00 | 2 500 | 38 260 575 | |
2018-03-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 15 000 | 1 530 323 | 0,99 | 24,84 | 372 600 | 38 013 223 | |
2018-03-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 15 000 | 1 515 323 | 1,00 | 25,15 | 377 250 | 38 110 373 | |
2018-03-01 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
P - Purchase | 10 000 | 626 142 | 1,62 | 62,59 | 625 910 | 39 190 854 | |
2018-02-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 13 165 028 | 0,08 | 25,21 | 252 100 | 331 890 356 | |
2018-02-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 13 155 028 | 0,08 | 25,16 | 251 600 | 330 980 504 | |
2018-02-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 13 145 028 | 0,15 | 24,95 | 499 000 | 327 968 449 | |
2018-02-01 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 132 | 1 908 | 7,43 | ||||
2018-01-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | −12 000 | 3 414 053 | −0,35 | 48,50 | −582 031 | 165 590 447 | |
2018-01-09 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | −4 000 | 3 426 053 | −0,12 | 47,02 | −188 080 | 161 093 012 | |
2017-12-22 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | −500 | 3 365 053 | −0,01 | 46,00 | −23 000 | 154 792 438 | |
2017-12-22 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
S - Sale | −3 500 | 3 365 553 | −0,10 | 44,40 | −155 400 | 149 430 553 | |
2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
M - Exercise | −8 181 | 0 | −100,00 | ||||
2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
M - Exercise | −44 670 | 0 | −100,00 | ||||
2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 8 181 | 13 169 698 | 0,06 | 14,37 | 117 561 | 189 248 560 | |
2017-12-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
M - Exercise | 44 670 | 13 116 847 | 0,34 | 6,48 | 289 462 | 84 997 169 | |
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −7 021 | 0 | −100,00 | ||||
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −7 021 | 0 | −100,00 | ||||
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −9 041 | 0 | −100,00 | ||||
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −8 081 | 0 | −100,00 | ||||
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
F - Taxes | −16 322 | 3 369 053 | −0,48 | 40,01 | −653 043 | 134 795 811 | |
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7 021 | 3 385 375 | 0,21 | 15,74 | 110 511 | 53 285 802 | |
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7 021 | 3 378 354 | 0,21 | 22,86 | 160 500 | 77 229 172 | |
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 9 041 | 3 371 333 | 0,27 | 21,07 | 190 494 | 71 033 986 | |
2017-12-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 8 081 | 3 362 292 | 0,24 | 23,70 | 191 520 | 79 686 320 | |
2017-11-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 5 500 | 1 500 323 | 0,37 | 22,00 | 121 000 | 33 007 106 | |
2017-11-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 1 494 823 | 0,67 | 21,18 | 211 800 | 31 660 351 | |
2017-11-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 1 484 823 | 0,68 | 20,80 | 208 000 | 30 884 318 | |
2017-11-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 1 474 823 | 0,68 | 19,19 | 191 900 | 28 301 853 | |
2017-11-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 1 464 823 | 1,38 | 18,98 | 379 600 | 27 802 341 | |
2017-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 24 581 | 1 444 823 | 1,73 | 18,81 | 462 369 | 27 177 121 | |
2017-11-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 26 600 | 1 420 242 | 1,91 | 18,54 | 493 164 | 26 331 287 | |
2017-11-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 50 000 | 1 393 642 | 3,72 | 18,46 | 923 000 | 25 726 631 | |
2017-11-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 50 000 | 1 343 642 | 3,87 | 18,73 | 936 500 | 25 166 415 | |
2017-11-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 1 293 642 | 0,01 | 19,00 | 1 900 | 24 579 198 | |
2017-11-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 340 864 | 1 293 542 | 35,78 | 18,51 | 6 309 393 | 23 943 462 | |
2017-11-01 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 141 | 1 776 | 8,62 | ||||
2017-10-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 45 000 | 13 040 117 | 0,35 | 20,14 | 906 300 | 262 627 956 | |
2017-10-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 13 250 | 12 995 117 | 0,10 | 20,29 | 268 842 | 263 670 924 | |
2017-10-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 59 922 | 12 981 867 | 0,46 | 20,07 | 1 202 635 | 260 546 071 | |
2017-10-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 32 060 | 12 954 005 | 0,25 | 19,72 | 632 223 | 255 452 979 | |
2017-10-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 29 240 | 12 921 945 | 0,23 | 18,81 | 550 004 | 243 061 785 | |
2017-10-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 276 200 | 12 892 705 | 2,19 | 19,74 | 5 452 188 | 254 501 997 | |
2017-10-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 51 600 | 12 616 505 | 0,41 | 20,27 | 1 045 932 | 255 736 556 | |
2017-09-05 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to Buy) |
X - Other | −773 003 | 0 | −100,00 | ||||
2017-09-05 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
X - Other | 773 003 | 3 905 223 | 24,68 | 1,00 | 773 003 | 3 905 223 | |
2017-08-29 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to Buy) |
P - Purchase | 773 003 | 773 003 | |||||
2017-08-29 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to Buy) |
H - Other | −773 003 | 0 | −100,00 | ||||
2017-08-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 12 730 | 12 564 905 | 0,10 | 21,76 | 277 005 | 273 412 333 | |
2017-08-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 37 270 | 12 552 175 | 0,30 | 21,34 | 795 342 | 267 863 414 | |
2017-08-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 8 200 | 12 514 905 | 0,07 | 21,35 | 175 070 | 267 193 222 | |
2017-08-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 23 400 | 12 506 705 | 0,19 | 21,35 | 499 590 | 267 018 152 | |
2017-08-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 80 000 | 12 483 305 | 0,64 | 21,43 | 1 714 400 | 267 517 226 | |
2017-08-02 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock Warrants |
P - Purchase | 185 392 | 485 062 | 61,87 | 4,00 | 741 568 | 1 940 248 | |
2017-08-02 |
|
4 | YTEN |
YIELD10 BIOSCIENCE, INC.
Common Stock |
P - Purchase | 185 392 | 1 383 421 | 15,47 | 4,00 | 741 568 | 5 533 684 | |
2017-08-01 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 129 | 1 635 | 8,57 | ||||
2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 24 255 | 10 238 756 | 0,24 | 1,52 | 36 943 | 15 594 649 | |
2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 9 100 | 10 214 501 | 0,09 | 1,44 | 13 146 | 14 755 868 | |
2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 8 002 | 10 205 401 | 0,08 | 1,39 | 11 124 | 14 187 548 | |
2017-07-13 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 2 200 | 10 197 399 | 0,02 | 1,41 | 3 096 | 14 350 800 | |
2017-05-26 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
M - Exercise | −495 | 0 | −100,00 | ||||
2017-05-26 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 495 | 616 142 | 0,08 | ||||
2017-05-26 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 1 506 | 1 506 | |||||
2017-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Options |
A - Award | 5 065 | 5 065 | |||||
2017-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 2 016 | 2 016 | |||||
2017-05-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 485 | 485 | |||||
2017-04-04 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 11 721 | 11 721 | |||||
2017-02-17 | 3 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
4 677 342 | ||||||||
2017-02-17 | 3 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
4 677 342 | ||||||||
2017-02-15 |
|
4 | VRML |
VERMILLION, INC.
Warrants (Right to buy) |
P - Purchase | 730 560 | 730 560 | 0,12 | 91 320 | 91 320 | ||
2017-02-15 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
P - Purchase | 974 081 | 3 132 220 | 45,14 | 1,40 | 1 363 713 | 4 385 108 | |
2017-01-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 128 368 | 952 678 | 15,57 | 19,00 | 2 438 992 | 18 100 882 | |
2017-01-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 211 000 | 12 403 305 | 1,73 | 19,00 | 4 009 000 | 235 662 795 | |
2016-12-21 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −2 864 | 615 647 | −0,46 | ||||
2016-10-07 |
|
4/A | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 33 762 | 4 213 429 | 0,81 | 0,95 | 32 074 | 4 002 758 | |
2016-10-04 |
|
4 | BIOL |
BIOLASE, INC
Series C Participating Convertible Preferred Stock |
C - Conversion | −36 991 | 0 | −100,00 | ||||
2016-10-04 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
C - Conversion | 3 699 100 | 10 195 199 | 56,94 | 1,13 | 4 179 983 | 11 520 575 | |
2016-08-03 |
|
4 | BIOL |
BIOLASE, INC
Warrants (right to buy) |
P - Purchase | 850 796 | 850 796 | 0,12 | 106 350 | 106 350 | ||
2016-08-03 |
|
4 | BIOL |
BIOLASE, INC
Series C Participating Convertible Preferred Stock |
P - Purchase | 36 991 | 36 991 | 113,00 | 4 179 983 | 4 179 983 | ||
2016-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 12 192 305 | 0,08 | 13,99 | 139 900 | 170 570 347 | |
2016-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 80 147 | 12 182 305 | 0,66 | 13,94 | 1 117 249 | 169 821 332 | |
2016-06-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 14 033 | 12 102 158 | 0,12 | 13,67 | 191 831 | 165 436 500 | |
2016-06-14 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 15 967 | 12 088 125 | 0,13 | 13,70 | 218 748 | 165 607 312 | |
2016-06-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1 000 | 12 072 158 | 0,01 | 15,00 | 15 000 | 181 082 370 | |
2016-06-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 87 316 | 824 310 | 11,85 | 14,69 | 1 282 672 | 12 109 114 | |
2016-06-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 75 000 | 736 994 | 11,33 | 14,17 | 1 062 750 | 10 443 205 | |
2016-06-10 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 26 272 | 661 994 | 4,13 | 14,07 | 369 647 | 9 314 256 | |
2016-05-31 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Put Option (obligation to buy) |
E - Other | −9 000 | 0 | −100,00 | ||||
2016-05-27 |
|
4 | SRCL |
STERICYCLE INC
Restricted Stock Units |
A - Award | 495 | 495 | |||||
2016-05-27 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3 713 | 3 713 | |||||
2016-05-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 4 270 | 12 071 158 | 0,04 | 11,04 | 47 141 | 133 265 584 | |
2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 7 021 | 7 021 | |||||
2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 962 | 962 | |||||
2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 908 | 908 | |||||
2016-05-19 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 3 027 | 3 027 | |||||
2016-05-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 12 066 888 | 0,08 | 11,45 | 114 500 | 138 165 868 | |
2016-05-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 11 511 | 12 056 888 | 0,10 | 11,91 | 137 096 | 143 597 536 | |
2016-05-16 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 12 045 377 | 0,17 | 12,45 | 249 000 | 149 964 944 | |
2016-04-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 8 181 | 74 937 | 12,26 | ||||
2016-02-22 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 500 | 6 547 537 | 0,01 | 0,80 | 400 | 5 238 030 | |
2016-02-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Put Option (obligation to buy) |
S - Sale | −9 000 | 9 000 | −50,00 | 100,00 | −900 000 | 900 000 | |
2016-02-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 900 | 6 547 037 | 0,01 | 0,80 | 720 | 5 237 630 | |
2016-02-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 3 200 | 6 546 137 | 0,05 | 0,80 | 2 554 | 5 224 472 | |
2016-02-16 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 500 | 6 542 937 | 0,01 | 0,78 | 388 | 5 083 862 | |
2016-02-16 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 18 580 | 6 542 437 | 0,28 | 0,76 | 14 041 | 4 944 120 | |
2016-02-11 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 54 187 | 6 523 857 | 0,84 | 0,77 | 41 952 | 5 050 770 | |
2016-02-11 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 13 026 | 6 469 670 | 0,20 | 0,79 | 10 285 | 5 108 451 | |
2016-02-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 76 790 | 12 032 376 | 0,64 | 10,63 | 816 278 | 127 904 157 | |
2016-02-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 600 000 | 11 955 586 | 5,28 | 11,86 | 7 116 000 | 141 793 250 | |
2016-02-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 11 355 586 | 0,18 | 12,32 | 246 400 | 139 900 820 | |
2016-02-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 7 308 | 11 335 586 | 0,06 | 12,65 | 92 446 | 143 395 163 | |
2016-02-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 11 328 278 | 0,09 | 12,98 | 129 800 | 147 041 048 | |
2016-02-04 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 50 100 | 11 318 278 | 0,44 | 13,09 | 655 809 | 148 156 259 | |
2016-02-03 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 11 268 178 | 0,18 | 13,46 | 269 200 | 151 669 676 | |
2016-02-01 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1 493 | 2 158 139 | 0,07 | 1,60 | 2 389 | 3 453 022 | |
2016-01-28 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1 750 | 2 156 646 | 0,08 | 1,59 | 2 782 | 3 429 067 | |
2016-01-28 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 700 | 2 154 896 | 0,03 | 1,60 | 1 120 | 3 447 834 | |
2016-01-27 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1 400 | 6 456 644 | 0,02 | 0,80 | 1 120 | 5 165 315 | |
2016-01-26 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 2 400 | 2 154 196 | 0,11 | 1,59 | 3 816 | 3 425 172 | |
2016-01-26 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1 300 | 2 151 796 | 0,06 | 1,53 | 1 989 | 3 292 248 | |
2016-01-25 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1 870 | 6 455 244 | 0,03 | 0,77 | 1 444 | 4 983 448 | |
2016-01-25 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 4 800 | 6 453 374 | 0,07 | 0,78 | 3 740 | 5 027 824 | |
2016-01-22 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 6 000 | 2 150 496 | 0,28 | 1,53 | 9 180 | 3 290 259 | |
2016-01-22 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 24 700 | 2 144 496 | 1,17 | 1,44 | 35 568 | 3 088 074 | |
2016-01-21 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 19 900 | 6 448 574 | 0,31 | 0,74 | 14 660 | 4 750 664 | |
2016-01-21 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 4 300 | 6 428 674 | 0,07 | 0,79 | 3 396 | 5 076 724 | |
2016-01-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 11 248 178 | 0,09 | 15,02 | 150 200 | 168 947 634 | |
2016-01-20 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 57 749 | 2 119 796 | 2,80 | 1,45 | 83 736 | 3 073 704 | |
2016-01-20 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 8 400 | 2 062 047 | 0,41 | 1,56 | 13 104 | 3 216 793 | |
2015-12-29 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 18 350 | 6 424 374 | 0,29 | 0,79 | 14 473 | 5 066 904 | |
2015-12-28 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 3 100 | 6 406 024 | 0,05 | 0,75 | 2 322 | 4 797 471 | |
2015-12-28 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 38 800 | 6 402 924 | 0,61 | 0,76 | 29 391 | 4 850 215 | |
2015-12-28 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2 500 | 11 231 179 | 0,02 | 18,20 | 45 500 | 204 407 458 | |
2015-12-23 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 87 200 | 6 364 124 | 1,39 | 0,74 | 64 511 | 4 708 179 | |
2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −165 | 618 511 | −0,03 | ||||
2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −6 722 | 618 676 | −1,07 | ||||
2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −71 800 | 625 398 | −10,30 | ||||
2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −15 | 697 198 | 0,00 | ||||
2015-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −36 | 697 213 | −0,01 | ||||
2015-12-22 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 126 919 | 6 276 924 | 2,06 | 0,73 | 93 184 | 4 608 518 | |
2015-12-22 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 973 | 6 150 005 | 0,02 | 0,68 | 662 | 4 185 693 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 64 865 | 5 885 603 | 1,11 | 0,93 | 60 324 | 5 473 611 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 200 | 5 820 738 | 0,00 | 0,95 | 190 | 5 529 701 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5 400 | 5 820 538 | 0,09 | 0,95 | 5 130 | 5 529 511 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 93 409 | 5 815 138 | 1,63 | 0,86 | 80 332 | 5 001 019 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 234 313 | 5 721 729 | 4,27 | 0,78 | 182 764 | 4 462 949 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 33 099 | 5 487 416 | 0,61 | 0,77 | 25 486 | 4 225 310 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 140 000 | 5 454 317 | 2,63 | 0,63 | 88 200 | 3 436 220 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 505 974 | 5 314 317 | 10,52 | 0,77 | 389 600 | 4 092 024 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5 671 | 4 808 343 | 0,12 | 0,90 | 5 104 | 4 327 509 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 9 900 | 4 802 672 | 0,21 | 0,91 | 9 009 | 4 370 432 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 23 500 | 4 792 772 | 0,49 | 0,92 | 21 620 | 4 409 350 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 48 250 | 4 769 272 | 1,02 | 0,92 | 44 390 | 4 387 730 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 541 355 | 4 721 022 | 12,95 | 0,92 | 498 047 | 4 343 340 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 52 103 | 4 179 667 | 1,26 | 0,95 | 49 498 | 3 970 684 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 25 510 | 4 127 564 | 0,62 | 0,95 | 24 234 | 3 921 186 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1 000 | 4 102 054 | 0,02 | 0,96 | 960 | 3 937 972 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 2 970 | 4 101 054 | 0,07 | 0,96 | 2 851 | 3 937 012 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 13 418 | 4 098 084 | 0,33 | 0,96 | 12 881 | 3 934 161 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 100 000 | 4 084 666 | 2,51 | 0,99 | 99 000 | 4 043 819 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 14 800 | 14 800 | 1,03 | 15 244 | 15 244 | ||
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 100 000 | 3 984 666 | 2,57 | 1,03 | 103 000 | 4 104 206 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 1 100 000 | 3 884 666 | 39,50 | 0,95 | 1 045 000 | 3 690 433 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 500 | 2 784 666 | 0,02 | 0,90 | 450 | 2 506 199 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 169 361 | 2 784 166 | 6,48 | 0,89 | 150 731 | 2 477 908 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 10 639 | 2 614 805 | 0,41 | 0,93 | 9 894 | 2 431 769 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 28 000 | 6 114 874 | 0,46 | 0,72 | 20 160 | 4 402 709 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 42 923 | 6 086 874 | 0,71 | 0,74 | 31 763 | 4 504 287 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 7 078 | 6 043 951 | 0,12 | 0,77 | 5 450 | 4 653 842 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 31 699 | 6 036 873 | 0,53 | 0,78 | 24 725 | 4 708 761 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5 704 | 6 005 174 | 0,10 | 0,79 | 4 506 | 4 744 087 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 14 596 | 5 999 470 | 0,24 | 0,79 | 11 531 | 4 739 581 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 8 561 | 5 984 874 | 0,14 | 0,80 | 6 849 | 4 787 899 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5 286 | 5 976 313 | 0,09 | 0,81 | 4 282 | 4 840 814 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 16 427 | 5 971 027 | 0,28 | 0,81 | 13 306 | 4 836 532 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 5 900 | 5 954 600 | 0,10 | 0,85 | 5 015 | 5 061 410 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 16 752 | 5 948 700 | 0,28 | 0,90 | 15 077 | 5 353 830 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 2 045 | 5 931 948 | 0,03 | 0,89 | 1 820 | 5 279 434 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 44 200 | 5 929 903 | 0,75 | 0,90 | 39 780 | 5 336 913 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 100 | 5 885 703 | 0,00 | 0,92 | 92 | 5 414 847 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 9 558 | 6 149 032 | 0,16 | 0,70 | 6 691 | 4 304 322 | |
2015-12-18 |
|
4 | BIOL |
BIOLASE, INC
Common Stock |
P - Purchase | 24 600 | 6 139 474 | 0,40 | 0,70 | 17 338 | 4 327 101 | |
2015-12-17 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2 352 941 | 11 238 178 | 26,48 | 17,00 | 39 999 997 | 191 049 026 | |
2015-11-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 11 899 | 10 890 669 | 0,11 | 16,81 | 200 022 | 183 072 146 | |
2015-11-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 51 337 | 10 878 770 | 0,47 | 16,80 | 862 462 | 182 763 336 | |
2015-11-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1 500 | 10 827 433 | 0,01 | 17,00 | 25 500 | 184 066 361 | |
2015-10-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 1 860 | 10 825 933 | 0,02 | 15,86 | 29 500 | 171 699 297 | |
2015-10-23 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 300 | 10 824 073 | 0,00 | 15,60 | 4 680 | 168 855 539 | |
2015-10-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 40 600 | 10 823 773 | 0,38 | 15,18 | 616 308 | 164 304 874 | |
2015-08-26 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 10 773 173 | 0,09 | 18,56 | 185 600 | 199 950 091 | |
2015-08-26 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 10 783 173 | 0,09 | 17,81 | 178 100 | 192 048 311 | |
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | −100 000 | 0 | −100,00 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | −100 000 | 0 | −100,00 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | −100 000 | 100 000 | −50,00 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | −100 000 | 200 000 | −33,33 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | −100 000 | 300 000 | −25,00 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series C Preferred Stock |
C - Conversion | −1 880 000 | 500 000 | −78,99 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series B-1 Preferred Stock |
C - Conversion | −453 982 | 0 | −100,00 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | −173 009 | 0 | −100,00 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
P - Purchase | 20 000 | 1 279 903 | 1,59 | 15,00 | 300 000 | 19 198 545 | |
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41 665 | 1 252 903 | 3,44 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41 665 | 1 252 903 | 3,44 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41 665 | 1 252 903 | 3,44 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41 665 | 1 211 238 | 3,56 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 41 665 | 1 127 908 | 3,84 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 783 332 | 1 044 578 | 299,84 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 189 159 | 261 246 | 262,40 | ||||
2015-07-28 |
|
4 | NEOS |
Neos Therapeutics, Inc.
Common Stock |
C - Conversion | 72 087 | 72 087 | |||||
2015-07-21 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 765 308 | 2 053 647 | 59,40 | 1,96 | 1 500 004 | 4 025 148 | |
2015-06-23 |
|
4 | MBLX |
METABOLIX, INC.
Common Stock Warrants |
P - Purchase | 1 498 356 | 1 498 356 | 0,12 | 187 294 | 187 294 | ||
2015-06-23 |
|
4 | MBLX |
METABOLIX, INC.
Common Stock |
P - Purchase | 1 664 840 | 2 185 652 | 319,66 | 3,32 | 5 527 269 | 7 256 365 | |
2015-06-15 |
|
4 | HNSN |
HANSEN MEDICAL INC
Stock Option (Right to Buy) |
A - Award | 60 000 | 60 000 | |||||
2015-05-29 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4 931 | 4 931 | |||||
2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 7 021 | 7 021 | |||||
2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 962 | 962 | |||||
2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 625 | 625 | |||||
2015-05-06 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 2 084 | 2 084 | |||||
2015-04-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 9 000 | 10 772 173 | 0,08 | 21,85 | 196 650 | 235 371 980 | |
2015-04-20 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2 000 | 10 763 173 | 0,02 | 22,33 | 44 660 | 240 341 653 | |
2015-04-06 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 7 658 | 66 756 | 12,96 | ||||
2015-03-17 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 4 000 | 10 761 173 | 0,04 | 20,55 | 82 200 | 221 142 105 | |
2015-03-09 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 22 584 | 10 757 173 | 0,21 | 17,18 | 387 993 | 184 808 232 | |
2015-01-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 3 000 | 10 734 589 | 0,03 | 18,27 | 54 810 | 196 120 941 | |
2015-01-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 5 000 | 10 731 589 | 0,05 | 18,43 | 92 150 | 197 783 185 | |
2015-01-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 10 726 589 | 0,09 | 19,37 | 193 700 | 207 774 029 | |
2014-12-29 |
|
4 | VRML |
VERMILLION, INC.
Warrant to acquire Common Stock |
P - Purchase | 773 003 | 773 003 | 0,12 | 96 625 | 96 625 | ||
2014-12-29 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
P - Purchase | 1 288 339 | 1 288 339 | 1,44 | 1 855 208 | 1 855 208 | ||
2014-12-23 |
|
4 | VRML |
VERMILLION, INC.
Warrant to Acquire Common Stock |
X - Other | 4 055 157 | 0 | −100,00 | ||||
2014-12-23 |
|
4 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 per share |
X - Other | 4 055 157 | 6 673 029 | 154,90 | 1,46 | 5 920 529 | 9 742 622 | |
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −39 | 697 249 | −0,01 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −62 | 697 288 | −0,01 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −1 028 | 697 350 | −0,15 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −345 | 698 378 | −0,05 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −1 688 | 698 723 | −0,24 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −40 | 700 411 | −0,01 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −37 | 700 451 | −0,01 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −30 | 700 488 | 0,00 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −44 | 700 518 | −0,01 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −44 | 700 562 | −0,01 | ||||
2014-12-23 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −43 | 700 606 | −0,01 | ||||
2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 9 041 | 9 041 | |||||
2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 417 | 417 | |||||
2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 678 | 678 | |||||
2014-11-18 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 2 261 | 2 261 | |||||
2014-11-13 | 3 | BIOL |
BIOLASE, INC
Common Stock |
5 208 332 | ||||||||
2014-11-13 | 3 | BIOL |
BIOLASE, INC
Common Stock |
5 208 332 | ||||||||
2014-09-24 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2 588 | 10 716 589 | 0,02 | 16,44 | 42 547 | 176 180 723 | |
2014-09-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 31 910 | 10 714 001 | 0,30 | 16,67 | 531 940 | 178 602 397 | |
2014-09-22 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 501 | 10 682 091 | 0,00 | 16,80 | 8 417 | 179 459 129 | |
2014-08-25 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 2 900 | 10 681 590 | 0,03 | 16,79 | 48 691 | 179 343 896 | |
2014-07-18 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 20 000 | 10 678 690 | 0,19 | 19,89 | 397 800 | 212 399 144 | |
2014-07-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 8 698 | 10 658 690 | 0,08 | 25,70 | 223 539 | 273 928 333 | |
2014-07-01 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 10 000 | 10 649 992 | 0,09 | 26,09 | 260 900 | 277 858 291 | |
2014-05-23 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4 359 | 4 359 | |||||
2014-05-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
A - Award | 863 072 | 10 639 992 | 8,83 | 16,80 | 14 499 610 | 178 751 866 | |
2014-05-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Subscription Rights (right to buy) |
X - Other | −587 401 | 0 | −100,00 | ||||
2014-05-02 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
X - Other | 587 401 | 9 776 920 | 6,39 | 16,80 | 9 868 337 | 164 252 256 | |
2014-04-30 |
|
4 | HNSN |
HANSEN MEDICAL INC
Stock Option (Right to Buy) |
A - Award | 30 000 | 30 000 | |||||
2014-04-07 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 14 428 | 59 098 | 32,30 | ||||
2014-03-21 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
S - Sale | −638 639 | 6 165 261 | −9,39 | 1,79 | −1 143 164 | 11 035 817 | |
2014-03-21 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
S - Sale | −115 492 | 6 803 900 | −1,67 | 1,90 | −219 435 | 12 927 410 | |
2014-03-21 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
S - Sale | −438 120 | 6 919 392 | −5,95 | 1,91 | −836 809 | 13 216 039 | |
2014-02-28 |
|
4 | HNSN |
HANSEN MEDICAL INC
Warrant (Right to Buy) |
X - Other | −3 744 094 | 0 | −100,00 | ||||
2014-02-28 |
|
4 | HNSN |
HANSEN MEDICAL INC
Common Stock |
X - Other | 3 744 094 | 13 233 640 | 39,45 | 1,23 | 4 605 236 | 16 277 377 | |
2013-12-31 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −900 | 700 649 | −0,13 | ||||
2013-12-30 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −18 630 | 701 549 | −2,59 | ||||
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 105 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 433 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 033 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −3 226 | 147 967 | −2,13 | 96,40 | −310 986 | 14 264 019 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −3 226 | 147 967 | −2,13 | 96,40 | −310 986 | 14 264 019 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
F - Taxes | −3 676 | 720 179 | −0,51 | 113,69 | −417 924 | 81 877 151 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 7 105 | 723 855 | 0,99 | 58,82 | 417 916 | 42 577 151 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
F - Taxes | −3 079 | 716 750 | −0,43 | 113,69 | −350 052 | 81 487 308 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 7 033 | 719 829 | 0,99 | 49,76 | 349 962 | 35 818 691 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
F - Taxes | −4 704 | 712 796 | −0,66 | 113,69 | −534 798 | 81 037 777 | |
2013-12-24 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
M - Exercise | 9 433 | 717 500 | 1,33 | 56,70 | 534 851 | 40 682 250 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −7 800 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −7 800 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −14 449 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −16 002 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −12 154 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −9 331 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
M - Exercise | −9 331 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
F - Taxes | −37 713 | 3 354 207 | −1,11 | 27,54 | −1 038 616 | 92 374 861 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7 800 | 3 391 920 | 0,23 | 15,73 | 122 694 | 53 354 902 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 7 800 | 3 384 120 | 0,23 | 14,43 | 112 554 | 48 832 852 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 14 449 | 3 376 320 | 0,43 | 13,25 | 191 449 | 44 736 240 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 16 002 | 3 361 871 | 0,48 | 11,96 | 191 384 | 40 207 977 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 12 154 | 3 345 869 | 0,36 | 16,25 | 197 502 | 54 370 371 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 9 331 | 3 333 715 | 0,28 | 13,97 | 130 354 | 46 571 999 | |
2013-12-24 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 9 331 | 3 324 384 | 0,28 | 9,93 | 92 657 | 33 011 133 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 500 | 9 189 519 | 0,01 | 13,14 | 6 570 | 120 750 280 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 500 | 9 189 019 | 0,01 | 13,02 | 6 510 | 119 641 027 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 300 | 9 188 519 | 0,00 | 12,89 | 3 867 | 118 440 010 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 9 188 219 | 0,00 | 12,84 | 1 284 | 117 976 732 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 9 188 119 | 0,00 | 12,82 | 1 282 | 117 791 686 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 3 000 | 9 188 019 | 0,03 | 12,30 | 36 900 | 113 012 634 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 6 900 | 9 185 019 | 0,08 | 12,27 | 84 663 | 112 700 183 | |
2013-10-29 |
|
4 | AXDX] |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 100 | 9 178 119 | 0,00 | 12,26 | 1 226 | 112 523 739 | |
2013-08-26 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
P - Purchase | 93 777 | 7 357 512 | 1,29 | 1,36 | 127 565 | 10 008 424 | |
2013-08-22 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
P - Purchase | 199 586 | 7 263 735 | 2,83 | 1,40 | 278 961 | 10 152 522 | |
2013-08-22 |
|
4 | GTXI |
GTX INC /DE/
Common Stock |
P - Purchase | 110 005 | 7 064 149 | 1,58 | 1,45 | 159 518 | 10 243 722 | |
2013-08-21 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 800 | 9 178 019 | 0,01 | 7,97 | 6 376 | 73 148 811 | |
2013-08-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 46 246 | 9 177 219 | 0,51 | 8,00 | 369 968 | 73 417 752 | |
2013-08-19 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 32 248 | 9 130 973 | 0,35 | 7,72 | 248 955 | 70 491 112 | |
2013-08-15 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
P - Purchase | 413 090 | 9 098 725 | 4,76 | 8,04 | 3 321 244 | 73 153 749 | |
2013-08-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Subscription Rights (right to buy) |
O - Other | −515 056 | 0 | −100,00 | ||||
2013-08-13 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
O - Other | 642 631 | 8 685 635 | 7,99 | 8,04 | 5 166 753 | 69 832 505 | |
2013-08-12 |
|
4 | HNSN |
HANSEN MEDICAL INC
Stock Option (Right to Buy) |
A - Award | 50 000 | 50 000 | |||||
2013-08-12 | 3 | HNSN |
HANSEN MEDICAL INC
Common Stock |
5 319 769 | ||||||||
2013-08-12 | 3 | HNSN |
HANSEN MEDICAL INC
Common Stock |
9 489 546 | ||||||||
2013-08-12 | 3 | HNSN |
HANSEN MEDICAL INC
Common Stock |
16 000 | ||||||||
2013-07-12 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −946 | 27 110 | −3,37 | 105,75 | −100 035 | 2 866 750 | |
2013-07-12 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −946 | 365 399 | −0,26 | 105,75 | −100 038 | 38 640 360 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −10 645 | 21 910 | −32,70 | 48,93 | −520 869 | 1 072 076 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −10 645 | 21 910 | −32,70 | 48,93 | −520 869 | 1 072 076 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −10 685 | 21 840 | −32,85 | 48,93 | −522 827 | 1 068 651 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −745 | 32 555 | −2,24 | 38,52 | −28 697 | 1 254 019 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −5 | 32 525 | −0,02 | 38,26 | −191 | 1 244 406 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −770 | 32 530 | −2,31 | 38,50 | −29 645 | 1 252 405 | |
2013-06-27 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −735 | 32 565 | −2,21 | 38,50 | −28 298 | 1 253 752 | |
2013-05-23 | 3 | VRML |
VERMILLION, INC.
Common Stock, par value $0.001 |
2 617 872 | ||||||||
2013-05-22 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 5 245 | 5 245 | |||||
2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 371 | 371 | |||||
2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 8 081 | 8 081 | |||||
2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium |
A - Award | 603 | 603 | |||||
2013-05-16 |
|
4 | QDEL |
QUIDEL CORP /DE/
Rstricted Stock Units (Converted) |
A - Award | 2 010 | 2 010 | |||||
2013-05-01 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
A - Award | 2 989 | 536 088 | 0,56 | ||||
2013-04-05 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Stock Option (right to buy) |
A - Award | 44 670 | 44 670 | |||||
2013-03-27 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −955 | 393 455 | −0,24 | 103,94 | −99 259 | 40 894 218 | |
2013-03-27 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −925 | 860 216 | −0,11 | 103,92 | −96 126 | 89 393 389 | |
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Warrants (right to buy) |
J - Other | −571 160 | 0 | −100,00 | ||||
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Warrants (right to buy) |
X - Other | −6 428 840 | 571 160 | −91,84 | ||||
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Warrants (right to buy) |
X - Other | −7 000 000 | 7 000 000 | −50,00 | ||||
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | 8 043 004 | 8 043 004 | |||||
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | −14 000 000 | 0 | −100,00 | ||||
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
J - Other | −13 428 840 | 14 000 000 | −48,96 | ||||
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
X - Other | 6 428 840 | 27 428 840 | 30,61 | 2,00 | 12 857 680 | 54 857 680 | |
2013-03-08 |
|
4 | AXDX |
Accelerate Diagnostics, Inc
Common Stock |
X - Other | 7 000 000 | 21 000 000 | 50,00 | 1,03 | 7 210 000 | 21 630 000 | |
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −3 521 | 861 141 | −0,41 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −212 000 | 864 662 | −19,69 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −100 000 | 1 275 104 | −7,27 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −3 124 | 1 375 104 | −0,23 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | 10 800 | 394 410 | 2,82 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −10 800 | 1 378 228 | −0,78 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | 16 300 | 383 610 | 4,44 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −16 300 | 29 340 | −35,71 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −45 000 | 1 389 028 | −3,14 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −5 000 | 1 434 028 | −0,35 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −51 070 | 1 539 018 | −3,21 | ||||
2012-12-31 |
|
5 | SRCL |
STERICYCLE INC
Common Stock |
G - Gift | −270 | 1 590 088 | −0,02 | ||||
2012-12-14 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −29 973 | 1 291 916 | −2,27 | 93,31 | −2 796 781 | 120 548 682 | |
2012-12-14 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −85 853 | 1 321 889 | −6,10 | 93,38 | −8 016 953 | 123 437 995 | |
2012-12-14 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −82 616 | 1 407 742 | −5,54 | 94,26 | −7 787 384 | 132 693 761 | |
2012-09-13 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −50 000 | 1 490 358 | −3,25 | 93,32 | −4 666 000 | 139 080 209 | |
2012-09-13 |
|
4 | SRCL |
STERICYCLE INC
Common Stock |
S - Sale | −50 000 | 1 540 358 | −3,14 | 92,98 | −4 649 000 | 143 222 487 | |
2012-07-03 |
|
4 | AXK |
ACCELR8 TECHNOLOGY CORP
Warrants (right to buy) |
P - Purchase | 7 000 000 | 14 000 000 | 100,00 | ||||
2012-07-03 |
|
4 | AXK |
ACCELR8 TECHNOLOGY CORP
Warrants (right to buy) |
P - Purchase | 7 000 000 | 14 000 000 | 100,00 | ||||
2012-07-03 |
|
4 | AXK |
ACCELR8 TECHNOLOGY CORP
Common Stock |
P - Purchase | 14 000 000 | 14 000 000 | 1,03 | 14 420 000 | 14 420 000 | ||
2012-07-03 | 3 | AXK |
ACCELR8 TECHNOLOGY CORP
Common Stock |
14 000 000 | ||||||||
2012-05-23 |
|
4 | SRCL |
STERICYCLE INC
Non-Qualified Stock Option (right to buy) |
A - Award | 5 960 | 5 960 | |||||
2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Equity Grant) |
A - Award | 2 600 | 2 600 | |||||
2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Non-Qualified Stock Option |
A - Award | 7 800 | 7 800 | |||||
2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Premium) |
A - Award | 740 | 740 | |||||
2012-05-17 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restricted Stock Units (Converted) |
A - Award | 2 469 | 2 469 | |||||
2012-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Restrict Stock Units (Equity Grant) |
M - Exercise | −2 600 | 0 | −100,00 | ||||
2012-05-14 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
M - Exercise | 2 600 | 3 315 053 | 0,08 | ||||
2012-05-02 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
A - Award | 3 665 | 532 484 | 0,69 | ||||
2012-03-21 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
P - Purchase | 40 000 | 3 311 465 | 1,22 | 16,65 | 665 928 | 55 129 932 | |
2012-03-21 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
P - Purchase | 15 815 | 3 271 465 | 0,49 | 16,48 | 260 577 | 53 902 620 | |
2012-03-21 |
|
4 | QDEL |
QUIDEL CORP /DE/
Common Stock |
P - Purchase | 10 000 | 3 255 650 | 0,31 | 16,60 | 165 954 | 54 028 814 | |
2012-03-05 |
|
4 | GTXI |
GTX INC /DE/
common stock |
P - Purchase | 796 923 | 6 954 144 | 12,94 | 3,33 | 2 653 754 | 23 157 300 | |
2012-03-05 |
|
4 | GTXI |
GTX INC /DE/
common stock |
P - Purchase | 69 700 | 5 632 320 | 1,25 | 3,33 | 232 101 | 18 755 626 | |
2012-03-05 |
|
4/A | GTXI |
GTX INC /DE/
common stock |
P - Purchase | 69 700 | 6 157 221 | 1,14 | 3,33 | 232 101 | 20 503 546 | |
2012-01-18 | 3 | MBLX |
METABOLIX, INC.
common stock, par value $.01 per share |
3 124 876 | ||||||||
2012-01-18 | 3 | MBLX |
METABOLIX, INC.
common stock, par value $.01 per share |
50 600 | ||||||||
2012-01-18 | 3 | MBLX |
METABOLIX, INC.
common stock, par value $.01 per share |
1 915 819 | ||||||||
2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | −296 | 2 667 288 | −0,01 | ||||
2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | −962 | 2 667 584 | −0,04 | ||||
2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | −185 | 2 668 546 | −0,01 | ||||
2009-01-23 |
|
5 | QDEL |
QUIDEL CORP /DE/
Common Stock |
G - Gift | −11 218 | 2 668 731 | −0,42 | ||||
2006-02-07 | 3 | QDEL |
QUIDEL CORP /DE/
Common Stock |
3 137 058 | ||||||||
2006-02-07 | 3 | QDEL |
QUIDEL CORP /DE/
Common Stock |
225 756 |